NEW YORK, Jan. 9, 2023 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Albireo Pharma, Inc. ("Albireo" or the "Company") (NASDAQ:ALBO), in connection with the proposed acquisition of the Company by Ipsen S.A. (OTC:IPSEY) via tender offer. Under the terms of the merger agreement, the Company's shareholders will receive $42.00 in cash for each share of Albireo common stock owned, plus one contingent value right ("CVR") per share. Each CVR will entitle its holder to deferred cash payments of $10.00 per CVR.
Read more at prnewswire.comSHAREHOLDER ALERT: Weiss Law Investigates Albireo Pharma, Inc.
PR Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
/AI%20(artificial%20intelligence)/AI%20engineer%20working%20on%20laptop%20by%20ART%20STOCK%20CREATIVE%20via%20Shutterstock.jpg)
/Nike%2C%20Inc_%20swish%20by-%20Tartezy%20via%20Shutterstock.jpg)